News
Zacks Investment Research on MSN3h
ARMP Soars 72% in a Month Following Infectious Disease Study SuccessArmata Pharmaceuticals ARMP shares have skyrocketed 72.3% in the past month. The massive surge in the stock price was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback